跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-AMOXI CLAV - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-AMOXI CLAV
Authorized
STANDARD
M-AMOXI CLAV
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4173ed51288398bd
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
4173ed51288398bd
Drug Approval Canada Name
M-AMOXI CLAV
Product Name
M-AMOXI CLAV
Status
Marketed
Status Date
2024-02-01
Original Market Date
2024-02-01
Din
02542226
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.16.08
Atc Original
J01CR02 AMOXICILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name
j 01 cr 02
Aig Number
0234720001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
AMOXICILLIN (AMOXICILLIN TRIHYDRATE)
250 MG / 5 ML
CLAVULANIC ACID (CLAVULANATE POTASSIUM)
62.5 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4173ed51288398bd
Type
Standard
Back to Health Canada Approvals